MétaCan
Menu
Retour à la cohorte
Enregistrement W2552135403 · doi:10.1182/blood.v124.21.2717.2717

Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease

2014· article· en· W2552135403 sur OpenAlexaboutno aff
Cody Cichowitz, C. Patrick Carroll, John J. Strouse, Carlton Haywood, Sophie Lanzkron

Notice bibliographique

RevueBlood · 2014
Typearticle
Langueen
DomaineMedicine
ThématiqueHemoglobinopathies and Related Disorders
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMontreal Cognitive AssessmentMedicinePopulationCognitionCronbach's alphaPediatricsPhysical therapyClinical psychologyPsychiatryCognitive impairmentPsychometrics

Résumé

récupéré en direct d'OpenAlex

Abstract Introduction: Studies have described neuroimaging abnormalities and neurocognitive dysfunction in adults living with sickle cell anemia and no previous history of neurological impairment. At the Johns Hopkins Sickle Cell Center for Adults, we have been administering the Montreal Cognitive Assessment (MoCA) at regularly scheduled outpatient appointments as part of routine screening and clinical care. The MoCA is scored out of 30 points and consists of 28 questions grouped into seven domains of cognitive function: visual-spatial and executive, naming, attention, language, abstraction, delayed recall and orientation. While the MoCA has yet to be validated as a screening tool for cognitive impairment in adults with sickle cell disease (SCD), it has been widely used and validated in other populations to screen for mild cognitive impairment with the cutoff typically ranging from 22 to 26. The objective of this study was to describe the results of MoCA testing in a sample of adults with SCD and to explore predictors of MoCA performance using data from a retrospective chart review. Methods: A cross-sectional study was completed of the first 100 MoCAs administered to adult patients with SCD. Demographic, laboratory and clinical data were collected from each participant’s medical record up to the date that the MoCA was administered. The internal validity of each MoCA domain was analyzed using standard psychometric statistics, including a Cronbach-α score and factor analysis. Bivariate analysis was completed using Mann–Whitney U tests and Spearman Rank correlations. We identified independent predictors of MoCA performance using a multivariable robust linear regression. Age, hemoglobin and genotype were included in the multivariable analysis along with any variable found to have an association with MoCA score (p-values ≤ .10). Results: The distribution of scores is displayed in Figure 1; the mean score was 24.5 with a standard deviation of 4.1. The visual-spatial and executive function and attention domains showed strong correlation with overall test performance and demonstrated high measures of internal validity. Education, gender, weight, aspartate aminotransferase, cerebral vascular accident (CVA), chronic kidney disease (CKD) and a history of hydroxyurea therapy were associated with MoCA scores in bivariate analysis. The results of multivariable analysis are displayed in Table 1. Education was found to be a significant independent predictor of increased MoCA score, while CVA and CKD were found to be significant predictors of decreased MoCA score. When limited to the 64 participants with SS or Sβ0 Thalassemia, education and a history of hydroxyurea therapy were found to be significant independent predictors of increased score, while CKD was found to be a significant predictor of decreased score. Conclusion: A screening tool for neurocognitive dysfunction in adults with SCD is needed in order to identify those that require more definitive testing. The significant association of MoCA score with both education and CVA supports the potential validity of this measure as a screening tool in this patient population. Further validation of this tool is needed as well as an exploration into the possible relationship between improved MoCA performance and hydroxyurea use. Figure 1 Figure 1. Table 1: Multivariable Analysis Model 1: Robust Linear Regression for MoCA Score (n = 89) Independent Variables Coefficient [95% Confidence Interval] P-value Education – Completed > 12th Grade 3.1 1.5 4.7 .0003 Gender - Male 1.4 -0.13 2.8 .0738 Age (years) -0.043 -0.11 0.024 .2055 Genotype – SS or Sβ0 Thalassemia 1.3 -1.3 3.9 .3350 Hemoglobin (g/dL) 0.033 -0.62 0.69 .9196 Weight (lbs) 0.014 -0.0052 0.034 .1504 Aspartate Aminotransferase (Units/L) -0.035 -0.078 0.0090 .1179 CVA -3.3 -5.7 -0.90 .0079 CKD -3.1 -6.2 -0.056 .0460 Model 2: Robust Linear Regression for MoCA Score for participants with SS or Sβ0 Thalassemia (n = 64) Independent Variables Coefficient [95% Confidence Interval] P-value Education – Completed > 12th Grade 3.7 2.2 5.2 .0000 Gender - Male 0.95 -0.71 2.6 .2561 Age (years) -0.043 -0.13 0.046 .3363 Hemoglobin (g/dL) -0.010 -0.69 0.67 .9770 Weight (lbs) 0.0067 -0.015 0.029 .5451 Aspartate Aminotransferase (Units/L) -0.044 -0.089 0.00062 .0531 CVA -1.9 -4.7 0.92 .1832 CKD -3.4 -6.4 -0.27 .0334 History of Hydroxyurea Therapy 2.1 0.14 4.0 .0364 Disclosures Haywood: NHLBI: Research Funding. Lanzkron:NHLBI: Research Funding.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,003
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,004
Score d'incertitude au seuil0,008

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0010,003
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0010,001
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0010,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,008
Tête enseignante GPT0,224
Écart entre enseignants0,216 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations5
Publié2014
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueBloodMême sujetHemoglobinopathies and Related DisordersTravaux en français237 207